IRD Chart
See on advanced chart >
About
Opus Genetics, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Opus's pipeline currently includes two small-molecule product candidates targeting...
Read More
- HighlightA clinical stage ophthalmic biopharmaceutical company developing treatments for hereditary retinal diseases (IRD) and other retinal and refractive disorders
- ExchangeNASDAQ
- Listing Date06/10/2019
- Established DateInvalid Date
- Full-time Employees14
- Address37000 Grand River Avenue Suite 120 Farmington Hills MI
- Tel1-248-9579024
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals